Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |